• Autophagy, Resveratrol, and Apoptosis in RCC

  2026-08-17

  Yao, Fan, and He showed that resveratrol induces ROS-associated mitochondrial damage and caspase-3-dependent apoptosis in renal cell carcinoma 786-O cells, while simultaneously activating JNK-linked autophagy. The study’s central implication is that autophagy functions as a protective response, making combined resveratrol and autophagy inhibition a mechanistically rational strategy for further investigation.

• Acetoacetic acid sodium salt in metabolic workflows

  2026-08-17

  Acetoacetic acid sodium salt provides a water-compatible way to model ketone-body exposure, fatty acid catabolism, and diabetes-associated metabolic imbalance. This guide combines practical dosing, sample handling, analytical controls, and isotope-standard lessons from a separate synthesis study to improve reproducibility.

• Novel Allosteric PDK4 Inhibitors: Evidence from 8c

  2026-08-16

  The 2019 Journal of Medicinal Chemistry study identified anthraquinone-derived allosteric inhibitors of pyruvate dehydrogenase kinase 4, with compound 8c showing 84 nM biochemical potency and activity in metabolic, allergic, and cancer-related preclinical models. Its integrated medicinal chemistry, pharmacokinetic, animal, cellular, and docking data support PDK4 as a tractable target while also defining important limits for translation beyond the reported models.

• ABT-263 (Navitoclax): Reliable Apoptosis Assays

  2026-08-15

  A scenario-based guide to using ABT-263 (Navitoclax), SKU A3007, for reproducible apoptosis, viability, and cytotoxicity workflows. It connects Bcl-2-family biology with practical solvent handling, assay design, orthogonal validation, and evidence-based product selection.

• RCN2 Drives ESCC Metastasis and Cisplatin Resistance

  2026-08-14

  The reference study identifies RCN2 as a driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance through UBR5-dependent ubiquitination and degradation of PPP2CA. Its integrated molecular, biochemical, clinical, and animal-model evidence places the RCN2–PPP2CA–PI3K-AKT axis at the center of an experimentally testable resistance mechanism.

• Reserpine (N1867): Workflow Guide

  2026-08-14

  This guide explains how to qualify, dissolve, store, and control Reserpine (SKU N1867) for neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research. It is intended for controlled laboratory use only and does not provide clinical, diagnostic, therapeutic, or veterinary guidance.

• Proteinase K: Selectivity in DNA and Protease Assays

  2026-08-13

  Proteinase K is more than a routine digestion reagent: its stability, substrate preference, and inhibitor profile make it a powerful tool for genomic DNA isolation and assay control. This article connects DNA purification practice with a SARS-CoV-2 protease-screening study to clarify when broad proteolysis improves, rather than obscures, experimental interpretation.

• HyperFluor 488 Goat Anti-Rabbit IgG Guide

  2026-08-13

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit primary antibodies in immunofluorescence, microscopy, flow cytometry, and related assays. It should not be used as a standalone antigen-binding reagent, with non-rabbit primary antibodies, or in workflows incompatible with sodium azide or fluorescent detection.

• Boc-D-FMK Workflows for Apoptosis Research

  2026-08-12

  Boc-D-FMK provides a practical way to suppress activated caspases while monitoring linked inflammatory signaling in cell and animal models. This guide connects apoptosis-focused workflows with renal endothelial, hepatocyte, and hypothesis-generating liver fibrosis applications, while emphasizing formulation, timing, controls, and interpretation limits.

• Wnt–BMP Patterning in Hemichordate Neuroectoderm

  2026-08-12

  Le Petillon and colleagues show that Wnt and BMP signals have distinct, temporally changing roles in patterning the anterior neuroectoderm of the indirect-developing hemichordate Ptychodera flava. The study links posterior Wnt activity to anterior restriction and identifies a biphasic BMP contribution to neuroectoderm formation and regeneration, refining models of deuterostome developmental conservation.

• Kupffer Cell Plasticity in Liver Metastasis

  2026-08-11

  The reference study shows that liver metastasis-associated macrophages are sustained not only by recruited monocytes but also by local macrophage proliferation and infiltration of reprogrammed Kupffer cells. Its lineage-tracing, depletion, proliferation-recording, flow-cytometry, immunofluorescence, and CITE-seq strategy provides a framework for distinguishing macrophage origin from macrophage state in metastatic liver tissue.

• Ceruletide Workflows for Pancreatic Fibrosis

  2026-08-10

  Ceruletide, also called Caerulein in pancreatic injury models, provides a defined CCK-receptor stimulus for pancreatic secretion, fibrosis, and gastrointestinal motility experiments. This practical guide connects dose planning, peptide handling, and orthogonal autophagy assays to the ORM2–ZG16 findings in chronic pancreatitis research.

• Malate as a Flux-Aware Metabolic Research Tool

  2026-08-09

  Malate, or (S)-2-hydroxysuccinic acid, is more than a TCA-cycle metabolite: it is a controllable handle for studying redox transfer, mitochondrial function, and metabolic flux. This article presents a flux-aware framework for using malate in mechanistic assays while clarifying what recent cholangiocarcinoma research does—and does not—establish.

• BV6 and Cell-Death Assay Design

  2026-08-08

  BV6 is an IAP antagonist for dissecting apoptosis, treatment sensitization, and cancer-cell survival. This article presents a pathway-aware assay framework that separates IAP-driven apoptosis from RIPK3–MLKL necroptosis and uses recent infection biology to improve experimental interpretation.

• Batimastat (BB-94) for MMP Mechanism Studies

  2026-08-07

  Batimastat (BB-94) provides a practical way to perturb zinc-dependent matrix metalloproteinase activity in cancer, extracellular-matrix, and neuromuscular assays. Its broad potency supports dose-response studies, while careful compartmental controls help distinguish extracellular BDNF processing from intracellular proteolysis.

555 records 8/37 page Previous Next First page 上5页 678910 下5页 Last page